We are live on ! Find out more
NPSP

NPS PHARMACEUTICALS INC
NPSP

Delisted

NPSP was delisted on the 20th of February, 2015.

Back to rankings

215 hedge funds and large institutions have $3.36B invested in NPS PHARMACEUTICALS INC in 2014 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 78 increasing their positions, 69 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more capital invested

Capital invested by funds: $2.89B → $3.36B (+$465M)

13% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 69

11% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 44

2% more funds holding

Funds holding: 210 → 215 (+5)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

12% less call options, than puts

Call options by funds: $72.5M | Put options by funds: $82M

Holders
215
Holders Change
+5
Holders Change %
+2.38%
% of All Funds
6.18%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
49
Increased
78
Reduced
69
Closed
44
Calls
$72.5M
Puts
$82M
Net Calls
-$9.5M
Net Calls Change
-$5.8M

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$65.5M
2
Norges Bank
Norges Bank
Norway
+$36.9M
3
Invesco
Invesco
Georgia
+$32.3M
4
VAM
Visium Asset Management
New York
+$29.5M
5
PC
PointState Capital
New York
+$24.6M

Top Sellers

Rank Fund Capital Flow
1
RIM
RS Investment Management
California
-$45.8M
2
CWAM
Columbia Wanger Asset Management
Illinois
-$29.9M
3
Franklin Resources
Franklin Resources
California
-$21.8M
4
CCM
Century Capital Management
Massachusetts
-$17.2M
5
TI
Turner Investments
Pennsylvania
-$14.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
PC
26
PointState Capital
New York
$28.1M +$24.6M +850,000 New
EAM
27
Eagle Asset Management
Florida
$25.4M -$280K -9,703 -1%
Bank of America
28
Bank of America
North Carolina
$22.5M +$9.37M +324,514 +91%
PAI
29
Palo Alto Investors
California
$20.1M +$5.03M +174,100 +40%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$19.7M +$1.71M +59,172 +11%
O
31
OrbiMed
New York
$18.2M +$15.9M +550,200 New
Morgan Stanley
32
Morgan Stanley
New York
$17.9M +$1.85M +64,209 +13%
O
33
OppenheimerFunds
New York
$17.2M -$5.64M -195,170 -27%
T. Rowe Price Associates
34
T. Rowe Price Associates
Maryland
$16.2M +$690K +23,900 +5%
AC
35
Apex Capital
California
$15.7M – – –
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
$14.4M -$2M -69,187 -14%
HCM
37
Harvey Capital Management
Florida
$14.3M +$207K +7,150 +2%
Allianz Asset Management
38
Allianz Asset Management
Germany
$13.9M -$481K -16,647 -4%
EPCM
39
Eton Park Capital Management
New York
$13.5M +$11.8M +408,141 New
JP Morgan Chase
40
JP Morgan Chase
New York
$12.6M -$13.1M -452,496 -54%
CPM
41
Chesapeake Partners Management
Maryland
$12.6M +$11M +380,756 New
PAM
42
Panagora Asset Management
Massachusetts
$12M -$216K -7,464 -2%
PCM
43
Pentwater Capital Management
Florida
$11.9M +$10.4M +360,000 New
AQR Capital Management
44
AQR Capital Management
Connecticut
$11.6M +$2.09M +72,400 +26%
RFC
45
Russell Frank Company
Washington
$11.4M +$5.85M +202,675 +107%
Citadel Advisors
46
Citadel Advisors
Florida
$10.5M -$1.12M -38,868 -11%
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$10.3M +$664K +22,975 +8%
EA
48
Emerald Advisers
Pennsylvania
$10.2M -$10.1M -350,676 -53%
Ameriprise
49
Ameriprise
Minnesota
$10.2M +$4.3M +148,755 +94%
Charles Schwab
50
Charles Schwab
California
$9.83M -$1.88M -65,212 -18%
1
2
3 4 5

NPSP Hedge Fund Activity: Q2 2014 in Review

215 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q2 2014, worth a combined $3.36B — up 16% from $2.89B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new NPSP positions and 44 closed out — a net gain of 5 holders — while 78 added to existing stakes and 69 trimmed.

The largest buyer was Wells Fargo, adding an estimated $65.5M. The largest seller was RS Investment Management, exiting entirely with an estimated $45.8M sold.

  • 215 institutional investors held NPS PHARMACEUTICALS INC (NPSP) as of Q2 2014, up from 210 in Q1 2014.
  • Funds reported $3.36B of NPS PHARMACEUTICALS INC stock for Q2 2014, up 16% quarter-over-quarter.
  • 49 funds opened new NPS PHARMACEUTICALS INC positions in Q2 2014 and 44 closed out, a net change of +5 holders.
  • The largest NPS PHARMACEUTICALS INC buyer in Q2 2014 was Wells Fargo, an estimated $65.5M added.
  • The largest NPS PHARMACEUTICALS INC seller in Q2 2014 was RS Investment Management, an estimated $45.8M sold.

Based on aggregated 13F filings for Q2 2014.